Nina Haldipur (MBA) is an operator turned investor with over 15 years of experience from healthcare multinationals and venture capital. After international roles in pharma (Novartis, Novo Nordisk), she transitioned to life science investment at EIFO and the BioInnovation Institute. She has a track record in backing science-based innovation and building resilient organisations.